IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.IDEXX Laboratories Inc. (IDXX) shares fell 2.01% to $552.46 on Tuesday, underperforming the broader market and several competitors despite a positive trading session for major indices. This marks the third consecutive day of losses for IDEXX, which is now trading 28.25% below its 52-week high. Trading volume remained significantly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) slipped 2.01% to $552.46 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of losses.
IDEXX Laboratories Inc. closed 28.25% below its 52-week high of $769.98, which the company achieved on November 26th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Medtronic PLC (MDT) fell 1.13% to $82.35, and Boston Scientific Corp. (BSX) fell 1.33% to $43.19.
Trading volume (409,292) remained 261,378 below its 50-day average volume of 670,670.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1651ET